Glenmark Pharmaceuticals Limited (GLENMARK.BO)
INR 1541.0
(1.1%)
INR 1541.0
(1.1%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 69.34 Billion INR | -49.64% |
| 2022 | 78.42 Billion INR | 6.03% |
| 2021 | 73.96 Billion INR | 8.61% |
| 2020 | 68.09 Billion INR | 7.03% |
| 2019 | 63.62 Billion INR | 7.09% |
| 2018 | 59.41 Billion INR | 7.45% |
| 2017 | 55.29 Billion INR | -7.37% |
| 2016 | 59.69 Billion INR | 24.41% |
| 2015 | 47.98 Billion INR | 9.22% |
| 2014 | 43.93 Billion INR | 13.52% |
| 2013 | 38.7 Billion INR | 22.08% |
| 2012 | 31.7 Billion INR | 18.5% |
| 2011 | 26.75 Billion INR | 36.68% |
| 2010 | 19.57 Billion INR | 32.13% |
| 2009 | 14.81 Billion INR | 19.37% |
| 2008 | 12.4 Billion INR | -6.93% |
| 2007 | 13.33 Billion INR | 67.92% |
| 2006 | 7.94 Billion INR | 111.27% |
| 2005 | 3.75 Billion INR | 10.36% |
| 2004 | 3.4 Billion INR | 69.16% |
| 2003 | 2.01 Billion INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 13.05 Billion INR | 7.47% |
| 2023 FY | 39.49 Billion INR | -49.64% |
| 2023 Q4 | 12.15 Billion INR | -14.91% |
| 2023 Q1 | 21.08 Billion INR | 19.63% |
| 2023 Q2 | 19.62 Billion INR | -6.89% |
| 2023 Q3 | 14.28 Billion INR | -27.25% |
| 2022 Q4 | 17.62 Billion INR | -20.84% |
| 2022 Q3 | 22.26 Billion INR | 16.75% |
| 2022 Q2 | 19.06 Billion INR | 11.64% |
| 2022 FY | 78.42 Billion INR | 6.03% |
| 2022 Q1 | 17.08 Billion INR | 11.1% |
| 2021 Q3 | 20.69 Billion INR | 4.43% |
| 2021 Q2 | 19.81 Billion INR | 9.67% |
| 2021 Q1 | 18.07 Billion INR | 26.57% |
| 2021 Q4 | 15.37 Billion INR | -25.71% |
| 2021 FY | 73.96 Billion INR | 8.61% |
| 2020 Q1 | 15 Billion INR | 7.3% |
| 2020 FY | 68.09 Billion INR | 7.03% |
| 2020 Q2 | 18.67 Billion INR | 24.42% |
| 2020 Q3 | 18.47 Billion INR | -1.07% |
| 2020 Q4 | 14.27 Billion INR | -22.71% |
| 2019 Q3 | 17.12 Billion INR | -3.67% |
| 2019 Q4 | 13.98 Billion INR | -18.31% |
| 2019 FY | 63.62 Billion INR | 7.09% |
| 2019 Q1 | 14.73 Billion INR | 16.61% |
| 2019 Q2 | 17.77 Billion INR | 20.64% |
| 2018 FY | 59.41 Billion INR | 7.45% |
| 2018 Q1 | 13.7 Billion INR | -6.36% |
| 2018 Q3 | 16.47 Billion INR | -0.68% |
| 2018 Q2 | 16.59 Billion INR | 21.05% |
| 2018 Q4 | 12.63 Billion INR | -23.31% |
| 2017 Q3 | 13.89 Billion INR | -5.59% |
| 2017 FY | 55.29 Billion INR | -7.37% |
| 2017 Q4 | 14.63 Billion INR | 5.3% |
| 2017 Q2 | 14.72 Billion INR | -8.44% |
| 2017 Q1 | 16.07 Billion INR | -2.4% |
| 2016 Q2 | 15.58 Billion INR | 21.19% |
| 2016 Q3 | 18.63 Billion INR | 19.6% |
| 2016 FY | 59.69 Billion INR | 24.41% |
| 2016 Q4 | 16.47 Billion INR | -11.61% |
| 2016 Q1 | 12.85 Billion INR | -11.65% |
| 2015 FY | 47.98 Billion INR | 9.22% |
| 2015 Q2 | 13.17 Billion INR | 15.46% |
| 2015 Q3 | 12.33 Billion INR | -6.43% |
| 2015 Q4 | 14.55 Billion INR | 18.04% |
| 2015 Q1 | 11.41 Billion INR | -16.81% |
| 2014 Q1 | 10.3 Billion INR | 3.37% |
| 2014 FY | 43.93 Billion INR | 13.52% |
| 2014 Q4 | 13.72 Billion INR | 20.76% |
| 2014 Q3 | 11.36 Billion INR | 1.25% |
| 2014 Q2 | 11.22 Billion INR | 8.87% |
| 2013 Q4 | 9.97 Billion INR | -6.28% |
| 2013 FY | 38.7 Billion INR | 22.08% |
| 2013 Q2 | 9.76 Billion INR | 17.2% |
| 2013 Q1 | 8.32 Billion INR | -13.1% |
| 2013 Q3 | 10.63 Billion INR | 8.99% |
| 2012 Q3 | 9.13 Billion INR | 12.42% |
| 2012 Q4 | 9.58 Billion INR | 4.92% |
| 2012 FY | 31.7 Billion INR | 18.5% |
| 2012 Q1 | 6.74 Billion INR | 2.92% |
| 2012 Q2 | 8.12 Billion INR | 20.55% |
| 2011 Q4 | 6.54 Billion INR | -0.89% |
| 2011 FY | 26.75 Billion INR | 36.68% |
| 2011 Q3 | 6.6 Billion INR | 0.0% |
| 2010 FY | 19.57 Billion INR | 32.13% |
| 2009 FY | 14.81 Billion INR | 19.37% |
| 2008 FY | 12.4 Billion INR | -6.93% |
| 2007 FY | 13.33 Billion INR | 67.92% |
| 2006 FY | 7.94 Billion INR | 111.27% |
| 2005 FY | 3.75 Billion INR | 10.36% |
| 2004 FY | 3.4 Billion INR | 69.16% |
| 2003 FY | 2.01 Billion INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Ajanta Pharma Limited | 21.06 Billion INR | -229.19% |
| Amrutanjan Health Care Limited | 1.55 Billion INR | -4354.81% |
| Sigachi Industries Limited | 2 Billion INR | -3363.074% |
| Bal Pharma Limited | 770.19 Million INR | -8902.986% |
| Ind-Swift Laboratories Limited | 6.19 Billion INR | -1019.414% |
| Medico Remedies Limited | 262.14 Million INR | -26351.321% |
| Lasa Supergenerics Limited | 121.02 Million INR | -57192.036% |
| Venus Remedies Limited | 2.18 Billion INR | -3076.992% |
| Sun Pharma Advanced Research Company Limited | -602.4 Million INR | 11610.601% |
| Alpa Laboratories Limited | 188.89 Million INR | -36608.515% |
| Nectar Lifesciences Limited | 2.97 Billion INR | -2233.08% |
| Shilpa Medicare Limited | 3.54 Billion INR | -1854.984% |
| Aarti Drugs Limited | 8.31 Billion INR | -733.801% |
| Lupin Limited | 123.71 Billion INR | 43.953% |
| Aurobindo Pharma Limited | 154.68 Billion INR | 55.172% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 44.621% |
| Windlas Biotech Limited | 1.33 Billion INR | -5079.306% |
| Suven Life Sciences Limited | -200.79 Million INR | 34632.662% |
| Eris Lifesciences Limited | 10.42 Billion INR | -565.023% |
| Valiant Laboratories Limited | -60.66 Million INR | 114402.634% |
| J. B. Chemicals & Pharmaceuticals Limited | 22.69 Billion INR | -205.466% |
| Solara Active Pharma Sciences Limited | 861.2 Million INR | -7951.62% |
| Ipca Laboratories Limited | 29.8 Billion INR | -132.609% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | -1776.384% |
| Achyut Healthcare Limited | 4.86 Million INR | -1426366.776% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 73.174% |
| Bajaj HealthCare Limited | 1.47 Billion INR | -4611.256% |
| RPG Life Sciences Limited | 2.48 Billion INR | -2692.612% |
| Mankind Pharma Limited | 44.52 Billion INR | -55.748% |
| Laurus Labs Limited | 24.62 Billion INR | -181.642% |
| Piramal Pharma Limited | 24.47 Billion INR | -183.359% |
| Syncom Formulations (India) Limited | 942.39 Million INR | -7257.876% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | -48.299% |
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | -158.92% |
| Unichem Laboratories Limited | 4.86 Billion INR | -1325.314% |
| Sequent Scientific Limited | 2.97 Billion INR | -2227.856% |
| Novartis India Limited | 1.32 Billion INR | -5125.756% |
| Wanbury Limited | 1.73 Billion INR | -3906.635% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | -1581.687% |
| Wockhardt Limited | 16.24 Billion INR | -326.974% |
| Themis Medicare Limited | 1.5 Billion INR | -4510.703% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | -10525.439% |
| Jubilant Pharmova Limited | 19.64 Billion INR | -253.004% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | -457.714% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 57.618% |
| Divi's Laboratories Limited | 32.44 Billion INR | -113.75% |
| NATCO Pharma Limited | 25.73 Billion INR | -169.43% |
| Gufic Biosciences Limited | 4.16 Billion INR | -1563.759% |
| IOL Chemicals and Pharmaceuticals Limited | 4.58 Billion INR | -1413.721% |
| Ind-Swift Limited | 2.17 Billion INR | -3091.694% |
| Procter & Gamble Health Limited | 5.78 Billion INR | -1099.373% |
| FDC Limited | 8.33 Billion INR | -731.946% |
| Krebs Biochemicals & Industries Limited | 192.72 Million INR | -35878.638% |
| Granules India Limited | 16.79 Billion INR | -312.759% |
| Medicamen Biotech Limited | 495.49 Million INR | -13894.198% |
| Alkem Laboratories Limited | 52.29 Billion INR | -32.59% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | -1014.316% |
| Biofil Chemicals and Pharmaceuticals Limited | 14.57 Million INR | -475496.549% |
| Brooks Laboratories Limited | 65.62 Million INR | -105569.842% |
| Megasoft Limited | 342.07 Million INR | -20170.806% |
| ZIM Laboratories Limited | 1.26 Billion INR | -5373.302% |
| Strides Pharma Science Limited | 14.38 Billion INR | -381.93% |
| Neuland Laboratories Limited | 8.24 Billion INR | -740.712% |
| Morepen Laboratories Limited | 6.16 Billion INR | -1025.424% |
| Hikal Limited | 3.14 Billion INR | -2106.134% |
| Indoco Remedies Limited | 6.04 Billion INR | -1047.771% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | -1089.099% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | -11075.362% |
| Mangalam Drugs & Organics Limited | 703.6 Million INR | -9755.039% |
| Hester Biosciences Limited | 1.27 Billion INR | -5344.239% |